Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

shutterstock_95714119

29% of breast cancer trials do not establish control arm, study says

September 28, 2017 Research and Development clinical trials, pharma, pharmaceutical

As part of the effort to conduct ethical and scientifically safe, effective clinical trials, the standard for researchers carrying out …
News
roche

Roche’s Tecentriq scores approvals in metastatic lung and bladder cancer

September 27, 2017 Research and Development, Sales and Marketing Cancer, EMA, EU, European Commission, Roche, bladder cancer, immunotherapy, lung cancer, pharma, tecentriq

It’s good news for Roche as the company’s immunotherapy drug Tecentriq secures approval from the European Commission to be used …
News
pulse-trace-163708_960_720

Improved heart attack test could save millions for NHS

September 27, 2017 Research and Development biotech, drugs, heart attack, pharma, pharmaceutical

A new research, funded by the British Heart Foundation, has led to the creation of a new heart attack test …
News
brexit_flag

EMA relocation will cause drug approval delays even in best case scenario, agency says

September 27, 2017 Research and Development EMA, brexit, pharma, pharmaceuticals

As a direct result of the UK’s referendum vote to leave the EU last year, the headquarters of the EMA, …
News
hurricane_maria

Devastation to Puerto Rico threatens global medicine supply

September 27, 2017 Medical Communications, Research and Development Puerto Rico, biotech, drugs, pharma, pharmaceutical

The destructive forces of Hurricane Maria have caused untold damage to the island nation, with a reported 13 people left …
News
brainss

Axovant shares capitulate after Alzheimer’s drug failure

September 26, 2017 Research and Development Alzheimer's, Axovant, biotech, drugs, pharma, pharmaceutical

Axovant Sciences was set up with just one drug candidate in its portfolio, and a risky one, at that. The …
News
online_version

New CMO hops onto Bicycle Therapeutics

September 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bicycle Therapeutics, GSK, Pfizer, biotech, drugs, pharma, pharmaceutical

Bicycle Therapeutics has moved to appoint industry veteran, Maria Koehler, to the position of Chief Medical Officer at the company. …
Appointment
tessa_hilado-web-aug2017-allergan

Allergan’s Executive VP and Chief Financial Officer steps down

September 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, appointment

Allergan has announced that its Executive Vice President and Chief Financial Officer Tessa Hilado intends to step down from her …
Appointment
shutterstock_95714119

Cancer trials underrepresent minorities and elderly, Mayo Clinic says

September 26, 2017 Manufacturing and Production, Research and Development clinical trials, pharma, pharmaceutical

New research conducted by the Mayo Clinic in Minnesota has found participant groups for clinical trials in cancer underrepresent ethnic …
News
pharmafocus_october__cover_2017

The October 2017 issue of Pharmafocus is now live!

September 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMA, Pharmafocus

The October edition of Pharmafocus is now live! You can read it here.
News
shutterstock_57369385

Refining the system: Improving patients’ access to medicine

September 25, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NCIE, drug access, eams, market access, pharma, pharmaceuticals

The MHRA and NICE have been slowly improving the ways that the UK’s patients access medicines, but now Brexit threatens …
Feature
allergan

Allergan posts disappointing data in NASH

September 25, 2017 Research and Development, Sales and Marketing Allergan, biotech, drugs, nash, pharma, pharmaceutical

It was only last year that Allergan decided to cough up $1.7 billion to acquire Tobira Therapeutics, with the main …
News
alnylam

Alnylam soars on likely first RNAi treatment approval

September 22, 2017 Medical Communications, Research and Development Alynylam, Sanofi, biotech, drugs, patisran, pharma, pharmaceutical

Alnylam has been plugging away in the RNAi-based treatment area for 15 years and, finally, has something to show for …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s been a great week for drug research and access, with the first-ever FDA approval of a biosimilar in cancer …
News

New therapy offers triple threat to HIV virus

September 22, 2017 Medical Communications, Research and Development HIV, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025